Clinical Trials Browser

CBLC137 × Clear all

NCT04870944 2026-02-24

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Phase 1/2 Recruiting

Diffuse Intrinsic Pontine Glioma, Lymphoma

NCT03727789 2024-03-27

CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma

Phase 1 Terminated

DermatologicSarcoma

Advanced Cutaneous Melanoma of the Extremity

NCT01905228 2020-12-10

A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm

Phase 1 Completed

Glioblastoma